One‐year follow‐up of a TRASER clinical trial for the treatment of nasal telangiectasias. Issue 1 (24th November 2017)

• Record Type: Journal Article
• Authors: Geddes‐Bruce, Elizabeth; Hamill, Selina S.; Zachary, Christopher B.; Friedman, Paul M.
• Other Names: Geronemus Roy G. guestEditor.; Brauer Jeremy A. guestEditor.
• Is Part Of: Lasers in surgery and medicine. Volume 50:Issue 1(2018)
• Page Start: 61
• Page End: 63
• Publication Date: 2017-11-24
• Subjects: TRASER -- laser -- telangiectasias -- vessels; Lasers in medicine -- Periodicals; Lasers in surgery -- Periodicals; 617
• DOI: 10.1002/lsm.22765
• Languages: English
• ISSNs: 0196-8092

Abstract

Abstract : Objectives: To evaluate the long‐term efficacy of treating nasal telangiectasias with the TRASER device. Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1‐year follow‐up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5‐point telangiectasia scale. The data was compiled and analyzed. Results: Of the subjects with available follow‐up data, 44% maintained "complete vessel clearance, " 44% dropped down one grade to "almost complete vessel clearance, " and 11% dropped down to "moderately clear vessel clearance." All showed clinically significant improvement in nasal telangiectasias from baseline. Conclusions: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1‐year follow‐up. Lasers Surg. Med. 50:61–63, 2018. © 2017 Wiley Periodicals, Inc.